Back to search

Article

Prognostic role and treatment tips of FHL1 expression in cytogenetically intermediate- and poor-risk acute myeloid leukemia

2020-03-13

Abstract excerpt

<h4>Background: </h4> Acute myeloid leukemia (AML) is a heterogeneous disorder of hematopoietic system, 35 to 40% of younger patients (<60 years) are recurrent, refractory or drug-resistant, which are canonically called as cytogenetically intermediate- and poor-risk AML (IP-AML). Identifying novel biomarkers is an urgent clinical need and research hotspot for treatment optimization. <h4>Methods:</h4> Bioinformatic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d7993eaf-d724-5d28-a2e4-c8da3f5fd345
DOI
10.21203/rs.3.rs-17167/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prognostic role and treatment tips of FHL1 expression in cytogenetically intermediate- and poor-risk acute myeloid leukemiaDOI 10.21203/rs.3.rs-17167/v1
Select a neighboring publication to make it the new centre.